Inventor
QIAN YIMIN
US75 patents
⚠️ This page may combine multiple inventors who share the name “QIAN YIMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARVINAS OPERATIONS INC
19 patentsUS11104666B2Aug 31, 2021
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC18 citations94
US10899742B1Jan 26, 2021
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC18 citations94
US11597720B2Mar 7, 2023
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC4 citations86
US11384063B2Jul 12, 2022
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS OPERATIONS INC2 citations73
US11191741B2Dec 7, 2021
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC3 citations73
US11427548B2Aug 30, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations72
US12577255B2Mar 17, 2026
MDM2-based modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12312316B2May 27, 2025
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC0 citations62
US12275716B2Apr 15, 2025
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations62
US12171831B2Dec 24, 2024
Compounds and methods for the targeted degradation of bromodomain- containing proteins
ARVINAS OPERATIONS INC0 citations62
US12172981B2Dec 24, 2024
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations62
US11857519B2Jan 2, 2024
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC0 citations62
US11554171B2Jan 17, 2023
Compounds and methods for the targeted degradation of bromodomain-containing proteins
ARVINAS OPERATIONS INC0 citations62
US10946017B2Mar 16, 2021
Tank-binding kinase-1 PROTACs and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US10865202B2Dec 15, 2020
Indole derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC1 citations62
US12264157B2Apr 1, 2025
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC0 citations61
US11512083B2Nov 29, 2022
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC1 citations61
US11584743B2Feb 21, 2023
Indole derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations58
HOFFMANN LA ROCHE
8 patentsUS7807674B2Oct 5, 2010
Thyroid hormone analogs
HOFFMANN LA ROCHE35 citations92
US7452882B2Nov 18, 2008
Thyroid hormone analogs
HOFFMANN LA ROCHE24 citations92
US9321738B2Apr 26, 2016
N-alkyltriazole compounds as LPAR antagonists
HOFFMANN LA ROCHE4 citations72
US7132425B2Nov 7, 2006
5-substituted-six-membered heteroaromatic glucokinase activators
HOFFMANN LA ROCHE9 citations72
US7652053B2Jan 26, 2010
Diaminocycloalkane MCH receptor antagonists
HOFFMANN LA ROCHE2 citations63
USRE46024EJun 7, 2016
Thyroid hormone analogs
HOFFMANN LA ROCHE2 citations62
US7067529B2Jun 27, 2006
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
HOFFMANN LA ROCHE4 citations62
US7741327B2Jun 22, 2010
Pyrrolidinone glucokinase activators
HOFFMANN LA ROCHE3 citations61
ACCUTAR BIOTECHNOLOGY INC
7 patentsUS11420956B2Aug 23, 2022
Ureas having Androgen Receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC6 citations86
US10800770B1Oct 13, 2020
Chroman derivatives having estrogen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC9 citations84
US11535606B2Dec 27, 2022
Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC4 citations73
US11312702B2Apr 26, 2022
Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC4 citations73
US11261178B2Mar 1, 2022
Chroman derivatives having estrogen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC5 citations73
US11220490B2Jan 11, 2022
Ureas having androgen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC2 citations73
US10836749B1Nov 17, 2020
Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof
ACCUTAR BIOTECHNOLOGY INC3 citations73
ARVINAS INC
6 patentsUS10647698B2May 12, 2020
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS INC31 citations98
US10772962B2Sep 15, 2020
Compounds and methods for the targeted degradation of bromodomain-containing proteins
ARVINAS INC15 citations94
US10730870B2Aug 4, 2020
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS INC25 citations93
US10723717B2Jul 28, 2020
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS INC16 citations85
US11352351B2Jun 7, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS INC4 citations73
US10604506B2Mar 31, 2020
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS INC3 citations73
BOLIN DAVID ROBERT
4 patentsUS8058299B2Nov 15, 2011
Diacylglycerol acyltransferase inhibitors
BOLIN DAVID ROBERT26 citations91
US8115011B2Feb 14, 2012
Diacylglycerol acyltransferase inhibitors
BOLIN DAVID ROBERT6 citations71
US8124766B2Feb 28, 2012
Inhibitors of diacylglycerol acyltransferase
BOLIN DAVID ROBERT5 citations61
US8324385B2Dec 4, 2012
Diacylglycerol acyltransferase inhibitors
BOLIN DAVID ROBERT4 citations60
MERCK SHARP & DOHME
2 patentsTIGER BIOTHERAPEUTICS INC
2 patentsVIA PHARMACEUTICALS INC
1 patentAccutar Biotechnology
1 patentShowing the top 50 of 75 patents by PatentIndex Score.